Fails 2 of 8 criteria. S5, analytical documentation: Each product page says the medication is third party lab tested, and no certificate of analysis or lot document is published. 1 more criterion also fails; see the table below.
At a glance
Zera HealthTelehealth service
6/8criteria passed
Price
Semaglutide $149 the first month (listed $249), then $179 a month
Sells
compounded semaglutide, compounded tirzepatide, GLP-1 oral tablet, and 8 more
Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.
A telehealth service selling compounded semaglutide and tirzepatide, an oral GLP-1 tablet, microdose GLP-1, sermorelin and NAD+ injections and nasal spray, with first-month prices set against struck-through figures. It names its compounding pharmacy but prints no company name or street address.
Operating entity No legal entity name appears in the footer, on the contact page, in the text message terms, the notice of privacy practices, the telehealth notice or the refund policy.
The evidence behind each disposition in the table above, where it appears, and its date.
S1PASSA licensed physician reviews each case, and prescriptions are issued only after an online consultation in which an independent licensed provider reviews the medical intake and health history.Source: Zera Health's website; Zera Health's our providers page.
S2PASSThe start button opens an eligibility assessment whose first step asks the buyer's sex, age and state, and the refund policy places the first charge at the completion of the intake form.Source: Zera Health's intake form page; Zera Health's cancellation and refund policy.
S3PASSThe footer on every page states that the compounded medications are prepared by Strive Pharmacy, a licensed 503A compounding pharmacy, and the refund policy says all compounded medications are dispensed through Strive Pharmacy.Source: Zera Health's website; Zera Health's cancellation and refund policy.
S4PASSEach product page states that compounded semaglutide is not FDA-approved and is not the same as Ozempic or Wegovy, the sermorelin page says the compounded formulation is not FDA-approved, and the footer repeats that compounded medications are not FDA-approved.Source: Zera Health's semaglutide product page; Zera Health's sermorelin product page; Zera Health's FAQ.
S5FAILEach product page says the medication is third party lab tested, and no certificate of analysis or lot document is published.Source: Zera Health's semaglutide product page.
S6FAILNo street address appears in the footer, on the contact page, in the text message terms, the notice of privacy practices, the telehealth notice or the refund policy. The contact page gives only a phone number and an email address.Source: Zera Health's contact page; Zera Health's terms; Zera Health's notice of privacy practices page; Zera Health's telehealth notice.
S7PASSCompounded semaglutide at $179 a month billed monthly or $149 a month billed every 3 months, with the page header printing $149 for the first month against a struck-through $249. Compounded tirzepatide at $255 a month or $215 on the quarterly plan, header $199 for the first month against $315. The oral GLP-1 tablet and the microdose plan at $179 or $149, headers $169 against $249 and $129 against $199. Sermorelin at $155 or $130, header $125 against $225, and NAD+ injection and nasal spray at $130 or $110, header $99 against $179. The home page announces a 40% off sale.Source: Zera Health's semaglutide product page; Zera Health's tirzepatide product page; Zera Health's GLP-1 oral product page; Zera Health's microdose GLP-1 product page; Zera Health's sermorelin product page; Zera Health's NAD+ product page; Zera Health's website.
S8PASSNo FDA warning letter names Zera Health, and no action has halted the business.Source: FDA warning-letter index.
Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, GLP-1 oral tablet, microdose GLP-1, sermorelin injection and ODT, NAD+ injection, NAD+ nasal spray, MIC+B12 injection, sildenafil and tadalafil, estradiol HRT, finasteride and minoxidil.
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.